|
 |
12th January 2021
A potential vaccine for multiple sclerosis
A potential mRNA vaccine for multiple sclerosis (MS) has been announced by a collaboration including BioNTech, with a study in mice showing great promise for improving symptoms and stopping disease progression.
Read more... |
|
|
 |
21st September 2020
Wall-mounted technology detects COVID-19 in the air
A new wall-mounted technology – BioCloud – can detect the presence of COVID-19 in the air, and trigger an alert system to provide real time notifications of the pathogen's presence, allowing outbreaks to be contained before they occur.
Read more... |
|
|
 |
5th April 2020
COVID-19 vaccine candidate shows promise
Researchers at University of Pittsburgh School of Medicine report the creation of a promising COVID-19 vaccine candidate – named PittCoVacc – and are hoping for a fast approval track, lasting less than the usual year of testing, by the U.S. Food and Drug Administration (FDA).
Read more... |
|
|
 |
28th March 2020
COVID-19 is natural, not man-made
Scientists report that the novel SARS-CoV-2 virus – which causes the COVID-19 disease, and is responsible for the current global pandemic – originated naturally, and not otherwise.
Read more... |
|
|
 |
15th March 2020
New coronavirus test is 10 times faster
The FDA has granted emergency authorisation for a new coronavirus test. The automated system provides a ten-fold improvement in the speed of patient testing, and is expected to supply about 400,000 test results per week.
Read more... |
|
|
 |
24th February 2020
Artificial intelligence creates new antibiotic
Using a machine-learning algorithm, researchers have identified a powerful new antibiotic compound. It can kill some of the world's most problematic disease-causing bacteria – including strains that are resistant to all existing antibiotics.
Read more... |
|
|
 |
17th February 2020
AI-developed drug could treat OCD
A new drug created with artificial intelligence (AI) to treat patients with obsessive-compulsive disorder (OCD) will be entering human clinical trials for the first time.
Read more... |
|
|